These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
476 related articles for article (PubMed ID: 17907099)
1. Beneficial effects of spironolactone on glomerular injury in streptozotocin-induced diabetic rats. Yuan J; Jia R; Bao Y J Renin Angiotensin Aldosterone Syst; 2007 Sep; 8(3):118-26. PubMed ID: 17907099 [TBL] [Abstract][Full Text] [Related]
2. [Effect of selective cyclooxygenase -2 inhibitor on the renal lesion of streptozotocin-induced diabetic rats and its possible mechanism]. Zuo Y; Gu Y; Ma J; Lin S Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(4):239-43. PubMed ID: 11953170 [TBL] [Abstract][Full Text] [Related]
3. Renoprotective effects of fenofibrate in diabetic rats are achieved by suppressing kidney plasminogen activator inhibitor-1. Chen LL; Zhang JY; Wang BP Vascul Pharmacol; 2006 May; 44(5):309-15. PubMed ID: 16624630 [TBL] [Abstract][Full Text] [Related]
4. Melatonin reduces urinary excretion of N-acetyl-beta-D-glucosaminidase, albumin and renal oxidative markers in diabetic rats. Oktem F; Ozguner F; Yilmaz HR; Uz E; Dündar B Clin Exp Pharmacol Physiol; 2006; 33(1-2):95-101. PubMed ID: 16445706 [TBL] [Abstract][Full Text] [Related]
5. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats. Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458 [TBL] [Abstract][Full Text] [Related]
6. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney. Lee EA; Seo JY; Jiang Z; Yu MR; Kwon MK; Ha H; Lee HB Kidney Int; 2005 May; 67(5):1762-71. PubMed ID: 15840023 [TBL] [Abstract][Full Text] [Related]
7. [Effect of aldosterone on the expression of plasminogen activator inhibitor-1 in renal mesangial cells: experiment with rat renal mesangial cells]. Yuan J; Jia RH; Bao Y Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2439-42. PubMed ID: 18036328 [TBL] [Abstract][Full Text] [Related]
8. Positive feedback loop between plasminogen activator inhibitor-1 and transforming growth factor-beta1 during renal fibrosis in diabetes. Seo JY; Park J; Yu MR; Kim YS; Ha H; Lee HB Am J Nephrol; 2009; 30(6):481-90. PubMed ID: 19786738 [TBL] [Abstract][Full Text] [Related]
9. [Effects of aldosterone on synthesis of fibronectin and expression of transforming growth factor-beta1 mRNA in cultured rat mesangial cells]. Li XD; Chen XW; Tang DS; Liang D; Liu HF Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Feb; 23(2):140-2. PubMed ID: 17286908 [TBL] [Abstract][Full Text] [Related]
10. Downregulation of apoptosis and modulation of TGF-β1 by sodium selenate prevents streptozotocin-induced diabetic rat renal impairment. Roy S; Dontamalla SK; Mondru AK; Sannigrahi S; Veerareddy PR Biol Trace Elem Res; 2011 Jan; 139(1):55-71. PubMed ID: 20174975 [TBL] [Abstract][Full Text] [Related]
12. Combined effects of moderately elevated blood glucose and locally produced TGF-beta1 on glomerular morphology and renal collagen production. Krag S; Nyengaard JR; Wogensen L Nephrol Dial Transplant; 2007 Sep; 22(9):2485-96. PubMed ID: 17452404 [TBL] [Abstract][Full Text] [Related]
13. Berberine ameliorates renal injury in streptozotocin-induced diabetic rats by suppression of both oxidative stress and aldose reductase. Liu WH; Hei ZQ; Nie H; Tang FT; Huang HQ; Li XJ; Deng YH; Chen SR; Guo FF; Huang WG; Chen FY; Liu PQ Chin Med J (Engl); 2008 Apr; 121(8):706-12. PubMed ID: 18701023 [TBL] [Abstract][Full Text] [Related]
14. Modulation of the transforming growth factor beta1 by vitamin E in early nephropathy. Cojocel C; Al-Maghrebi M; Thomson MS; Rawoot P; Raghupathy R Med Princ Pract; 2005; 14(6):422-9. PubMed ID: 16220017 [TBL] [Abstract][Full Text] [Related]
15. Imbalance of glomerular VEGF-NO axis in diabetic rats: prevention by chronic therapy with propyl gallate. Tian S; Gan Y; Li J; Wang L; Shen J; Liu T; Ye T; Liu H; Liu D; Deng Y; Wang W J Nephrol; 2011; 24(4):499-506. PubMed ID: 21425119 [TBL] [Abstract][Full Text] [Related]
16. [Renal protective effects of sulodexide in diabetic rats and its anti-oxidative mechanism]. Shu J; Zeng LY; Lin KY; Mu PW; Zhang GC; Chen YM; Wang MM Nan Fang Yi Ke Da Xue Xue Bao; 2009 Apr; 29(4):778-80. PubMed ID: 19403420 [TBL] [Abstract][Full Text] [Related]
17. Influence of C-peptide on early glomerular changes in diabetic mice. Maezawa Y; Yokote K; Sonezaki K; Fujimoto M; Kobayashi K; Kawamura H; Tokuyama T; Takemoto M; Ueda S; Kuwaki T; Mori S; Wahren J; Saito Y Diabetes Metab Res Rev; 2006; 22(4):313-22. PubMed ID: 16389646 [TBL] [Abstract][Full Text] [Related]
18. Effect of enalapril and losartan on the events that precede diabetic nephropathy in rats. Volpini RA; da Silva CG; Costa RS; Coimbra TM Diabetes Metab Res Rev; 2003; 19(1):43-51. PubMed ID: 12592643 [TBL] [Abstract][Full Text] [Related]
19. Effect of probucol on mRNA expression of glomerular antioxidant enzymes in rat with subtotal nephrectomy. Tang Z; Ji D; Li L; Fukui M; Tomino Y; Koide H Chin Med J (Engl); 1996 Oct; 109(10):780-6. PubMed ID: 9275355 [TBL] [Abstract][Full Text] [Related]
20. Effects of melatonin on lipid peroxidation and antioxidant enzymes in streptozotocin-induced diabetic rat testis. Armagan A; Uz E; Yilmaz HR; Soyupek S; Oksay T; Ozcelik N Asian J Androl; 2006 Sep; 8(5):595-600. PubMed ID: 16752005 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]